Tuesday, September 29, 2015

PARADIGM Drug Dose Reduction Doesn't Cut Benefit

(MedPage Today) -- Similar benefit with LCZ696 vs ACE inhibitor across lower achieved doses in trial substudy

No comments:

Post a Comment